Fareston

— THERAPEUTIC CATEGORIES —
  • Breast cancer

Fareston Generic Name & Formulations

General Description

Toremifene (as citrate) 60mg; tabs.

Pharmacological Class

Nonsteroidal antiestrogen.

How Supplied

Tabs—30, 100

Manufacturer

Fareston Indications

Indications

Metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumors.

Fareston Dosage and Administration

Adult

60mg once daily. Continue until disease progression is observed.

Children

Not applicable.

Fareston Contraindications

Contraindications

Congenital/acquired QT prolongation. Uncorrected hypokalemia or hypomagnesemia.

Fareston Boxed Warnings

Boxed Warning

QT prolongation.

Fareston Warnings/Precautions

Warnings/Precautions

Avoid in long QT syndrome. CHF. Hepatic impairment. Electrolyte abnormalities. Correct hypokalemia or hypomagnesemia prior to initiation; monitor periodically during therapy. Pre-existing endometrial hyperplasia; long-term therapy not established. Do baseline and annual gynecological exam; esp. monitor those at high risk of endometrial cancer. History of thromboembolic disease: not recommended. Bone metastases; monitor for hypercalcemia during first weeks of treatment, discontinue if severe. Leukopenia, thrombocytopenia; obtain leukocyte and platelet counts. Monitor CBCs, ECGs, calcium levels, liver function tests periodically. Pregnancy (Cat.D). Females of reproductive potential should use effective non-hormonal contraception. Nursing mothers: not recommended.

Fareston Pharmacokinetics

See Literature

Fareston Interactions

Interactions

Caution with drugs that decrease renal calcium excretions (eg, thiazide diuretics). Avoid concomitant with drugs that prolong QT interval including Class 1A (eg, quinidine, procainamide, disopyramide) and Class III (eg, amiodarone, sotalol, ibutilide, dofetilide) antiarrhythmics, certain antipsychotics (eg, thioridazine, haloperidol), certain antidepressants (eg, venlafaxine, amitriptyline), certain antibiotics (eg, erythromycin, clarithromycin, levofloxacin, ofloxacin), certain anti-emetics (eg, ondansetron, granisetron); if needed, interrupt toremifene therapy; if interruption not possible, then monitor closely. Potentiated by strong CYP3A4 inhibitors (eg, ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconazole). Avoid grapefruit juice. Antagonized by strong CYP3A4 inducers (eg, dexamethasone, phenobarbital, phenytoin, carbamazepine, rifampin, rifabutin, St. John's Wort). Caution with concomitant CYP2C9 substrates with a narrow therapeutic index (eg, warfarin, phenytoin); monitor.

Fareston Adverse Reactions

Adverse Reactions

Hot flashes, sweating, nausea, vaginal discharge, dizziness, edema, vomiting, vaginal bleeding; Torsade de pointes, hepatotoxicity, hypercalcemia, tumor flare, endometrial hyperplasia; rare: leukopenia, thrombocytopenia.

Fareston Clinical Trials

See Literature

Fareston Note

Not Applicable

Fareston Patient Counseling

See Literature